Innocan Pharma Corp (INNO.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,373 | 4,089 | 4,947 | 6,416 | 7,726 |
| Receivables | 451 | 322 | 243 | 170 | 249 |
| Inventories | 1,417 | 1,281 | 1,131 | 969 | 751 |
| Other current assets | 102 | 103 | 104 | 105 | 109 |
| TOTAL | $5,760 | $6,257 | $6,878 | $8,223 | $9,388 |
| Non-Current Assets | |||||
| PPE Net | 142 | 141 | 98 | 93 | 80 |
| TOTAL | $142 | $141 | $98 | $93 | $80 |
| Total Assets | $5,902 | $6,398 | $6,976 | $8,316 | $9,468 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 177 | 289 | 95 | 139 | 248 |
| Accrued Expenses | N/A | N/A | 318 | N/A | N/A |
| Other current liabilities | 378 | 386 | 304 | 502 | 1,597 |
| TOTAL | $873 | $1,033 | $731 | $1,030 | $2,304 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 4 | 127 | 169 | 206 | 213 |
| TOTAL | $26 | $26 | $20 | $25 | $12 |
| Total Liabilities | $899 | $1,059 | $751 | $1,055 | $2,316 |
| Shareholders' Equity | |||||
| Retained earnings | -30,164 | -29,644 | -28,374 | -27,167 | -26,997 |
| TOTAL | $5,007 | $5,466 | $6,394 | $7,467 | $7,365 |
| Total Liabilities And Equity | $5,906 | $6,525 | $7,145 | $8,522 | $9,681 |